The Role of the Soluble CD30 Serum Level in Colorectal Cancer: A Possible Marker for a Patient Subset Which Could Benefit from IL-2 Biotherapy
- DOI
- 10.1089/cbr.1997.12.297
- Published
- 1997-10
- Container
- Cancer Biotherapy and Radiopharmaceuticals
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1089/cbr.1997.12.297,
title = {The Role of the Soluble CD30 Serum Level in Colorectal Cancer: A Possible Marker for a Patient Subset Which Could Benefit from IL-2 Biotherapy},
author = {Tiziana Del Beato and Anna Maria Berghella and Patrizia Pellegrini and Adorno Domenico and Carlo Umberto Casciani},
year = {1997},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
doi = {10.1089/cbr.1997.12.297},
url = {https://doi.org/10.1089/cbr.1997.12.297}
}RIS
TY - JOUR TI - The Role of the Soluble CD30 Serum Level in Colorectal Cancer: A Possible Marker for a Patient Subset Which Could Benefit from IL-2 Biotherapy AU - Tiziana Del Beato AU - Anna Maria Berghella AU - Patrizia Pellegrini AU - Adorno Domenico AU - Carlo Umberto Casciani PY - 1997 JO - Cancer Biotherapy and Radiopharmaceuticals DO - 10.1089/cbr.1997.12.297 UR - https://doi.org/10.1089/cbr.1997.12.297 ER -
APA
Beato, T. D., Berghella, A. M., Pellegrini, P., Domenico, A., & Casciani, C. U. (1997). The Role of the Soluble CD30 Serum Level in Colorectal Cancer: A Possible Marker for a Patient Subset Which Could Benefit from IL-2 Biotherapy. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.1997.12.297
Source records
- crossref · retrieved 2026-09-27T07:27:02.320Z